Investing.com - Nemaura Medical reported on Tuesday second quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Nemaura Medical announced earnings per share of $-0.170 on revenue of $74.03K. Analysts polled by Investing.com EPS of $-0.170 on revenue of $133.33K.
Nemaura Medical 's are down 64% and is trading at $2.240 , still down 62.29% from its 52 week high of $5.94 set on Friday, December 10, 2021.
Nemaura Medical shares gained 0.45% to trade at $2.240 in intra-day trade the report.
Nemaura Medical follows other major Healthcare sector earnings this month
Nemaura Medical's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar